Prostate-Specific Membrane Antigen

What Prostate-Specific Membrane Antigen Means in Everyday Medical Language

Prostate-Specific Membrane Antigen, often called PSMA, is a protein normally found on prostate cells. In prostate cancer, especially when the cancer is more advanced, PSMA is found in higher amounts on the surface of cancer cells. This makes PSMA a useful marker for doctors to identify prostate cancer cells in the body.

Why PSMA Can Matter in Cancer Care

Because PSMA is more common on prostate cancer cells, it can be used to help find and treat the cancer. Imaging tests called PSMA PET scans use substances that attach to PSMA, allowing doctors to see where cancer cells are located, including areas where the cancer may have spread. This helps in diagnosis, staging, and monitoring the disease.

PSMA is also the target of newer treatments like Pluvicto (lutetium Lu 177 vipivotide tetraxetan). This drug combines a radioactive element with a molecule that binds to PSMA, delivering radiation directly to cancer cells. This targeted approach aims to kill cancer cells while reducing harm to healthy tissue. It is used for prostate cancer that has spread and no longer responds to hormone-lowering treatments.

What Patients Might See or Hear About PSMA

You might hear PSMA mentioned in your medical reports, imaging results, or treatment discussions. For example, a doctor might order a PSMA PET scan to look for prostate cancer spread. If your cancer cells have enough PSMA, treatments like Pluvicto may be considered. This drug might be called by different names, including lutetium Lu 177 vipivotide tetraxetan or Lu-PSMA-617.

Because PSMA appears in different contexts—imaging, treatment, or lab tests—it’s helpful to ask your care team what it means for your specific situation. Understanding how PSMA relates to your cancer can help you follow your care plan and treatment options.

How Doctors Use PSMA in Diagnosis and Treatment

Doctors use PSMA to improve imaging tests that detect prostate cancer cells, especially when the cancer has returned or spread. PSMA PET scans provide detailed pictures that help guide treatment decisions. Before using PSMA-targeted treatments like Pluvicto, doctors test to confirm that cancer cells have enough PSMA for the treatment to work.

PSMA-targeted therapies are usually given after other treatments, such as hormone therapy and chemotherapy, have been tried. These therapies deliver radiation directly to cancer cells, aiming to slow tumor growth or shrink tumors while limiting side effects.

Common Questions and How to Talk With Your Care Team

If you see PSMA mentioned in your care, you might wonder what it means for your diagnosis or treatment. You can ask your healthcare provider how PSMA testing or treatments fit into your care plan, what benefits and risks to expect, and how it compares to other options.

It’s also important to understand that not all prostate cancers have enough PSMA for these tests or treatments to be useful. Your care team can explain what your specific test results mean and whether PSMA-targeted approaches are right for you.

Understanding the Information and Next Steps

This information about PSMA is meant to help you understand a protein that plays a role in prostate cancer detection and treatment. It does not replace personalized medical advice. If PSMA or related treatments come up in your care, the best next step is to talk with your healthcare team. They can explain what it means for your situation and help you make informed decisions about your care.